Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

8.900 -0.240 (-2.63%)

Streaming Delayed Price Updated: 1:37 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week ↗

January 25, 2024

The widely followed growth stock investor is adding to some of her holdings this week.

Via The Motley Fool

Evaluating Ginkgo Bioworks Holdings: Insights From 4 Financial Analysts ↗

January 23, 2024

Via Benzinga

NuStar Energy, Spirit Airlines, Fastly And Other Big Stocks Moving Higher On Monday ↗

January 22, 2024

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Monday. Shares of NuStar Energy L.P. (NYSE: NS) rose sharply during Monday’s session after Sunoco announced it will...

Via Benzinga

Topics Stocks

Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares ↗

January 17, 2024

Via Benzinga

3 Pricey Stocks I'll Be Watching Like a Hawk in 2024 ↗

January 14, 2024

Good things come to those who wait.

Via The Motley Fool

2 Cathie Wood Stocks That Might Be Smart Buys Right Now ↗

December 17, 2023

These two biotech stocks hold enormous potential.

Via The Motley Fool

Where Will Ginkgo Bioworks Be in 5 Years? ↗

November 24, 2023

Ginkgo Bioworks has been securing deals with many top companies, but will they pay off for the business?

Via The Motley Fool

Flexsteel Industries Posts Strong Preliminary Results, Joins Wipro, Sify Technologies And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

January 12, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining around 50 points on Friday.

Via Benzinga

Topics Stocks

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments ↗

January 10, 2024

Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million.

Via Benzinga

3 Cathie Wood Stocks to Start Off Your New Year Right ↗

January 10, 2024

The following stocks could deliver big gains over time.

Via The Motley Fool

Better Growth Investment: Ginkgo Bioworks vs. Shiba Inu ↗

January 09, 2024

Both of these investments need to prove that they can actually grow.

Via The Motley Fool

4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024 ↗

January 08, 2024

Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.

Via The Motley Fool

2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street ↗

January 08, 2024

Find out why investment bank analysts are hyperbullish for these stocks.

Via The Motley Fool

5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024 ↗

January 06, 2024

You'll find exciting innovators across industries.

Via The Motley Fool

This Artificial Intelligence Stock Could Be Like Buying Amazon in 1997 ↗

December 28, 2023

Ginkgo Bioworks has frequently been compared to Amazon in the media.

Via The Motley Fool

Topics Artificial Intelligence

Could Ginkgo Bioworks Stock Help You Become a Millionaire? ↗

December 24, 2023

It's easy to see a way for this to be a huge business in the future, but the path ahead of it is by no means a smooth one.

Via The Motley Fool

Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday? ↗

December 19, 2023

Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758...

Via Benzinga

As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist? ↗

December 18, 2023

Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF (IBB) was down 7.5% while the S&P 500 was up more than 14%.

Via Benzinga

Topics ETFs

AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗

December 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Via InvestorPlace

Topics Artificial Intelligence

5 Beaten-Down Stocks That Could Soar in 2024 ↗

December 16, 2023

These players may offer your portfolio a lift as early as next year. But most importantly, they could excel over time.

Via The Motley Fool

3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year ↗

December 13, 2023

These players could lift your portfolio when they rebound and over the long term.

Via The Motley Fool

If You Invested $1,000 in Ginkgo Bioworks in 2021, This Is How Much You Would Have Today ↗

December 01, 2023

Ginkgo's future may be promising, but whether the company can realize its potential is debatable.

Via The Motley Fool

Looking for Growth? 2 Top Stocks to Buy Hand Over Fist ↗

December 01, 2023

These stocks offer enormous long-term growth potential.

Via The Motley Fool

7 Small-Cap Stocks to Buy BEFORE the Year-End Rally ↗

November 30, 2023

explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy

Via InvestorPlace

3 Synthetic Biology Stocks Likely to Mint New Millionaires ↗

November 29, 2023

Synthetic biology stocks are strongly worth considering for several reasons, particularly these three stocks.

Via InvestorPlace

Dutch ingredients Firm Vivici Partners With Ginkgo Bioworks For Alternative Protein Development ↗

November 27, 2023

Dutch B2B ingredients company Vivici BV has partnered with biotech company Ginkgo Bioworks Holdings Inc (NYSE: DNA) to develop and commercialize

Via Benzinga

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth ↗

November 23, 2023

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy.

Via InvestorPlace

3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report ↗

November 17, 2023

Favorable trends are continuing, but there are new headwinds too.

Via The Motley Fool

7 Stocks Most Likely to Follow in WeWork’s Woeful Footsteps ↗

November 15, 2023

These troubled stocks to sell look even worse following WeWork's bankruptcy and will only hurt holders the longer they hold on.

Via InvestorPlace

Topics Bankruptcy

3 Cutting-Edge Biotech Stocks for the Bold Investor ↗

November 14, 2023

With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.